Neuregulin-1, a member of the epidermal growth factor family, mitigates STING-mediated pyroptosis and necroptosis in ischaemic flaps

Abstract

Background: Ensuring the survival of the distal end of a random flap during hypoperfusion (ischaemia) is difficult in clinical practice. Effective prevention of programmed cell death is a potential strategy for inhibiting ischaemic flap necrosis. The activation of stimulator of interferon genes (STING) pathway promotes inflammation and leads to cell death. The epidermal growth factor family member neuregulin-1 (NRG1) reduces cell death by activating the protein kinase B (AKT) signalling pathway. Moreover, AKT signalling negatively regulates STING activity. We aimed to verify the efficacy of NRG1 injection in protecting against flap necrosis. Additionally, we investigated whether NRG1 effectively enhances ischemic flap survival by inhibiting pyroptosis and necroptosis through STING suppression. Methods: A random-pattern skin flap model was generated on the backs of C57BL/6 mice. The skin flap survival area was determined. The blood supply and vascular network of the flap was assessed by laser Doppler blood flow analysis. Cluster of differentiation 34 immunohistochemistry (IHC) and haematoxylin and eosin (H&E) staining of the flap sections revealed microvessels. Transcriptome sequencing analysis revealed the mechanism by which NRG1 promotes the survival of ischaemic flaps. The levels of angiogenesis, oxidative stress, necroptosis, pyroptosis and indicators associated with signalling pathways in flaps were examined by IHC, immunofluorescence and Western blotting. Packaging adeno-associated virus (AAV) was used to activate STING in flaps. Results: NRG1 promoted the survival of ischaemic flaps. An increased subcutaneous vascular network and neovascularization were found in ischaemic flaps after the application of NRG1. Transcriptomic gene ontology enrichment analysis and protein level detection indicated that necroptosis, pyroptosis and STING activity were reduced in the NRG1 group. The phosphorylation of AKT and forkhead box O3a (FOXO3a) were increased after NRG1 treatment. The increased expression of STING in flaps induced by AAV reversed the therapeutic effect of NRG1. The ability of NRG1 to phosphorylate AKT-FOXO3a, inhibit STING and promote flap survival was abolished after the application of the AKT inhibitor MK2206. Conclusions: NRG1 inhibits pyroptosis and necroptosis by activating the AKT-FOXO3a signalling pathway to suppress STING activation and promote ischaemic flap survival.

Keywords

Neuregulin-1 / STING / Pyroptosis / Necroptosis / Ischaemic flaps / Epidermal growth factor

References

[1] Charafeddine AH, Drake R, McBride J. et al. Facelift: History and Anatomy. Clin Plast Surg 2019; 46: 505-13.

[2] Summers BK, Siegle RJ. Facial cutaneous reconstructive surgery: general aesthetic principles. J Am Acad Dermatol 1993; 29: 669-81.

[3] Chung S, Hazen A, Levine JP. et al. Vascularized acellular dermal matrix island flaps for the repair of abdominal muscle defects. Plast Reconstr Surg 2003; 111: 225-32.

[4] Chen Z, Wu H, Yang J. et al. Activating Parkin-dependent mitophagy alleviates oxidative stress, apoptosis, and promotes random-pattern skin flaps survival. Communications Biology 2022; 5: 616.

[5] Weinzierl A, Ampofo E, Menger MD. et al. Tissue-Protective Mechanisms of Bioactive Phytochemicals in Flap Surgery. Front Pharmacol 2022; 13: 864351. https://doi.org/10.3389/fphar.2022.864351.

[6] Man SM, Karki R, Kanneganti T-D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 2017; 277: 61-75.

[7] Chen D-Q, Guo Y, Li X. et al. Small molecules as modulators of regulated cell death against ischemia/reperfusion injury. Med Res Rev 2022; 42: 2067-101.

[8] Wu L, Zhao H, Zhang M. et al. Regulated cell death and inflamasome activation in gut injury following traumatic surgery in vitro and in vivo: implication for postoperative death due to multiorgan dysfunction. Cell Death Discovery 2023; 9: 409.

[9] Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. Trends Biochem Sci 2017; 42: 245-54.

[10] Sun Y-B, Zhao H, Mu D-L. et al. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis 2019; 10: 167.

[11] Zhao H, Ning J, Lemaire A. et al. Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. Kidney Int 2015; 87: 738-48.

[12] Lou J, Wang X, Zhang H. et al. Inhibition of PLA2G4E/cPLA2 promotes survival of random skin flaps by alleviating Lysosomal membrane permeabilization-Induced necroptosis. Autophagy 2022; 18: 1841-63.

[13] Galluzzi L, Kepp O, Chan FK-M. et al. Necroptosis: Mechanisms and Relevance to Disease. Annu Rev Pathol 2017; 12: 103-30.

[14] Lou J, Zhang H, Qi J. et al. Cyclic helix B peptide promotes random-pattern skin flap survival via TFE3-mediated enhancement of autophagy and reduction of ROS levels. Br J Pharmacol 2022; 179: 301-21.

[15] Li Q, Chen Q, Yang X. et al. Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive. Journal of Nanobiotechnology 2022; 20: 84.

[16] Oduro PK, Zheng X, Wei J. et al. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Acta Pharm Sin B 2022; 12: 50-75.

[17] Hu Q, Ren H, Li G. et al. STING-mediated intestinal barrier dysfunction contributes to lethal sepsis. EBioMedicine 2019; 41: 497-508.

[18] Luo W, Wang Y, Zhang L. et al. Critical Role of Cytosolic DNA and Its Sensing Adaptor STING in Aortic Degeneration, Dissection, and Rupture. Circulation 2020; 141: 42-66.

[19] Bartus K, Galino J, James ND. et al. Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury. Brain 2016; 139: 1394-416.

[20] Figliolini F, Ranghino A, Grange C. et al. Extracellular Vesicles From Adipose Stem Cells Prevent Muscle Damage and Inflammation in a Mouse Model of Hind Limb Ischemia: Role of Neuregulin-1. Arterioscler Thromb Vasc Biol 2020; 40: 239-54.

[21] Kang W, Cheng Y, Wang X. et al. Neuregulin-1: An underlying protective force of cardiac dysfunction in sepsis (Review). Mol Med Rep 2020; 21: 2311-20.

[22] Hedhli N, Huang Q, Kalinowski A. et al. Endothelium-derived neuregulin protects the heart against ischemic injury. Circulation 2011; 123: 2254-62.

[23] Wang F, Wang H, Liu X. et al. Neuregulin-1 alleviate oxidative stress and mitigate inflammation by suppressing NOX4 and NLRP3/caspase-1 in myocardial ischaemia-reperfusion injury. J Cell Mol Med 2021; 25: 1783-95.

[24] Jarde T, Chan WH, Rossello FJ. et al. Mesenchymal Niche-Derived Neuregulin-1 Drives Intestinal Stem Cell Proliferation and Regeneration of Damaged Epithelium. Cell Stem Cell 2020; 27: 646-662.e7.

[25] Yoon D, Yoon D, Cha HJ. et al. Enhancement of wound healing efficiency mediated by artificial dermis functionalized with EGF or NRG1. Biomed Mater 2018; 13: 045007. https://doi.org/10.1088/1748-605X/aaac37.

[26] Wu S, Zhang Q, Zhang F. et al. HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity. Nat Cell Biol 2019; 21: 1027-40.

[27] Zhou K, Chen H, Lin J. et al. FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival. Cell Death Dis 2019; 10: 872.

[28] Lou J, Wang X, Zhang H. et al. Inhibition of PLA2G4E/cPLA2 promotes survival of random skin flaps by alleviating Lysosomal membrane permeabilization-Induced necroptosis. Autophagy 2021; 18: 1841-63.

[29] Li J, Chen H, Lou J. et al. Exenatide improves random-pattern skin flap survival via TFE3 mediated autophagy augment. J Cell Physiol 2021; 236: 3641-59.

[30] Liu M, Solomon W, Cespedes JC. et al. Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling. J Neuroinflammation 2018; 15: 104.

[31] Hirai H, Sootome H, Nakatsuru Y. et al. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther 2010; 9: 1956-67.

[32] Odake K, Tsujii M, Iino T. et al. Febuxostat treatment attenuates oxidative stress and inflammation due to ischemia-reperfusion injury through the necrotic pathway in skin flap of animal model. Free Radic Biol Med 2021; 177: 238-46.

[33] Li J, Lou J, Yu G. et al. Targeting TFE3 Protects Against Lysosomal Malfunction-Induced Pyroptosis in Random Skin Flaps via ROS Elimination. Frontiers In Cell and Developmental Biology 2021; 9: 643996. https://doi.org/10.3389/fcell.2021.643996.

[34] Yang N, Yu G, Lai Y. et al. A snake cathelicidin enhances transcription factor EB-mediated autophagy and alleviates ROS-induced pyroptosis after ischaemia-reperfusion injury of island skin flaps. Br J Pharmacol 2024; 181: 1068-90.

[35] Zhang T, Wang Y, Inuzuka H. et al. Necroptosis pathways in tumorigenesis. Semin Cancer Biol 2022; 86: 32-40.

[36] Hu X, Zhang H, Zhang Q. et al. Emerging role of STING signalling in CNS injury: inflammation, autophagy, necroptosis, ferroptosis and pyroptosis. J Neuroinflammation 2022; 19: 242.

[37] Qiao J, Sun J, Chen L. et al. Neuregulin-1/ErbB4 upregulates acetylcholine receptors via Akt/mTOR/p70S6K: a study in a rat model of obstetric brachial plexus palsy and. Acta Biochim Biophys Sin 2022; 54: 1648-57.

[38] Yoo J-Y, Kim H-B, Baik T-K. et al. Neuregulin 1/ErbB4/Akt signaling attenuates cytotoxicity mediated by the APP-CT31 fragment of amyloid precursor protein. Exp Mol Pathol 2021; 120: 104622. https://doi.org/10.1016/j.yexmp.2021.104622.

[39] Shen Q, Yang L, Li C. et al. Metformin promotes cGAS/STING signaling pathway activation by blocking AKT phosphorylation in gastric cancer. Heliyon 2023; 9(8): e18954. https://doi.org/10.1016/j.heliyon.2023.e18954.

[40] Zhu D, Chen B, Xiang Z. et al. Apigenin enhances viability of random skin flaps by activating autophagy. Phytotherapy Research: PTR 2021; 35: 3848-60.

[41] Zhang D, Yuan Y, Zhang H. et al. Photoacoustic Microscopy Provides Early Prediction of Tissue Necrosis in Skin Avulsion Injuries. Clin Cosmet Investig Dermatol 2021;Volume 14: 837-44.

[42] Jiang J, Dong C, Zhai L. et al. Paeoniflorin Suppresses TBHP-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells via the Nrf2/HO-1 Signaling Pathway and Improves Skin Flap Survival. Front Pharmacol 2021; 12: 735530. https://doi.org/10.3389/fphar.2021.735530.

[43] Wang X, Zhuo X, Gao J. et al. Neuregulin-1beta Partially Improves Cardiac Function in Volume-Overload Heart Failure Through Regulation of Abnormal Calcium Handling. Front Pharmacol 2019; 10: 616.

[44] Wang X, Liu Z, Duan HN. et al. Therapeutic Potential of Neuregulin in Cardiovascular System: Can we Ignore the Effects of Neuregulin on Electrophysiology? Mini Rev Med Chem 2016; 16: 867-71.

[45] Jabbour A, Hayward CS, Keogh AM. et al. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail 2011; 13: 83-92.

[46] Gonkowski S.Neuregulin 1 (NRG1) and its receptors in the enteric nervous system and other parts of the gastrointestinal wall. Histol Histopathol 2024; 18721. https://doi.org/10.14670/HH-18-721.

[47] Hui T, Wang C, Yu L. et al. Phosphorene hydrogel conduits as "neurotrophin reservoirs" for promoting regeneration of peripheral nerves. J Mater Chem B 2023; 11: 3808-15.

[48] Gao R, Zhang J, Cheng L. et al. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol 2010; 55: 1907-14.

[49] Xu J, Sun P, Zhao X. et al. Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects. Am J Cardiovasc Drugs 2023; 23: 419-28.

[50] Zhu X, Hu X, Lou J. et al. Liraglutide, a TFEB-Mediated Autophagy Agonist, Promotes the Viability of Random-Pattern Skin Flaps. Oxidative Med Cell Longev 2021; 2021: 6610603-18.

[51] He JB, Ma XY, Li WJ. et al. Exenatide inhibits necrosis by enhancing angiogenesis and ameliorating ischemia/reperfusion injury in a random skin flap rat model. Int Immunopharmacol 2021; 90: 107192. https://doi.org/10.1016/j.intimp.2020.107192.

[52] Gui C, Zeng ZY, Chen Q. et al. Neuregulin-1 Promotes Myocardial Angiogenesis in the Rat Model of Diabetic Cardiomyopathy. Cell Physiol Biochem 2018; 46: 2325-34.

[53] Hedhli N, Dobricki LW, Kalinowski A. et al. Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesis. Cardiovasc Res 2012; 93: 516-24.

[54] Xu B, Iida Y, Glover KJ. et al. Inhibition of VEGF (Vascular Endothelial Growth Factor)-A or its Receptor Activity Suppresses Experimental Aneurysm Progression in the Aortic Elastase Infusion Model. Arterioscler Thromb Vasc Biol 2019; 39: 1652-66.

[55] Ahmad A, Nawaz MI.Molecular mechanism of VEGF and its role in pathological angiogenesis. J Cell Biochem 2022; 123: 1938-65.

[56] Swetha R, Gayen C, Kumar D. et al. Biomolecular basis of matrix metallo proteinase-9 activity. Future Med Chem 2018; 10: 1093-112.

[57] Krishna K, Redies C. Expression of cadherin superfamily genes in brain vascular development. J Cereb Blood Flow Metab 2009; 29: 224-9.

[58] Xu J, Su X, Burley SK. et al. Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and Cancer. Antioxidants (Basel) 2022; 11. https://doi.org/10.3390/antiox11020427.

[59] Chiang SK, Chen SE, Chang LC. The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival. Cells 2021; 10. https://doi.org/10.3390/cells10092401.

[60] Li H, Horke S, Forstermann U. Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 2013; 34: 313-9.

[61] Tang R, Xu J, Zhang B. et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol 2020; 13: 110.

[62] Zhang Q, Jia M, Wang Y. et al. Cell Death Mechanisms in Cerebral Ischemia-Reperfusion Injury. Neurochem Res 2022; 47: 3525-42.

[63] Shi J, Zhao Y, Wang K. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015; 526: 660-5.

[64] He S, Liang Y, Shao F. et al. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci USA 2011; 108: 20054-9.

[65] Kaiser WJ, Sridharan H, Huang C. et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 2013; 288: 31268-79.

[66] Lim J, Park H, Heisler J. et al. Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins. elife 2019; 8: 8.

[67] Tenev T, Bianchi K, Darding M. et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011; 43: 432-48.

[68] Feoktistova M, Geserick P, Kellert B. et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011; 43: 449-63.

[69] Zhao J, Jitkaew S, Cai Z. et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 2012; 109: 5322-7.

[70] Murphy JM, Czabotar PE, Hildebrand JM. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-53.

[71] Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 2021; 18: 1106-21.

[72] Cho YS, Challa S, Moquin D. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137: 1112-23.

[73] Li J, McQuade T, Siemer AB. et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012; 150: 339-50.

[74] Zhong Z, Liang S, Sanchez-Lopez E. et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature 2018; 560: 198-203.

[75] Liu Z, Wang M, Wang X. et al. XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biol 2022; 52: 102305. https://doi.org/10.1016/j.redox.2022.102305.

[76] Hopfner K-P, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol 2020; 21: 501-21.

[77] Gaidt MM, Ebert TS, Chauhan D. et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3. Cell 2017; 171: 1110-1124.e18.

[78] Zhang X, Wu J, Liu Q. et al. mtDNA-STING pathway promotes necroptosis-dependent enterocyte injury in intestinal ischemia reperfusion. Cell Death Dis 2020; 11: 1050.

[79] Brault M, Olsen TM, Martinez J. et al. Intracellular Nucleic Acid Sensing Triggers Necroptosis through Synergistic Type I IFN and TNF Signaling. J Immunol(Baltimore, Md. : 1950) 2018; 200: 2748-56.

[80] Zhang R, Kang R, Tang D. The STING1 network regulates autophagy and cell death. Signal Transduction and Targeted Therapy 2021; 6: 208.

[81] Hwang I, Uchida H, Dai Z. et al. Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification. Nat Commun 2021; 12: 640.

[82] Orea-Soufi A, Paik J, Bragança J. et al. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci 2022; 43: 1070-84.

[83] Liu W, Li Y, Luo B. Current perspective on the regulation of FOXO4 and its role in disease progression. Cellular and Molecular Life Sciences: CMLS 2020; 77: 651-63.

[84] Klotz L-O, Sánchez-Ramos C, Prieto-Arroyo I. et al. Redox regulation of FoxO transcription factors. Redox Biol 2015; 6: 51-72.

[85] Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261-74.

[86] Ding Z, Dai C, Zhong L. et al. Neuregulin-1 converts reactive astrocytes toward oligodendrocyte lineage cells via upregulating the PI3K-AKT-mTOR pathway to repair spinal cord injury. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 2021; 134: 111168. https://doi.org/10.1016/j.biopha.2020.111168.

[87] Bolino A, Piguet F, Alberizzi V. et al. Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination. EMBO Molecular Medicine 2016; 8: 1438-54.

[88] Liu T, Zhang L, Joo D. et al. NF-kappaB signaling in inflammation. Signal Transduct Target Ther 2017; 2: 17023.